3T Biosciences
An immunotherapy company developing next-generation, transformative therapies for broad patient populations.
Portfolio Items
Post Type Description
Acelyrin
A late-stage clinical biopharma company focused on providing life-changing new treatment options for patients.
Arsenal
A clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer.
Borealis Biosciences
A next-generation RNA medicines company that is advancing a novel platform to enable precision targeting of RNA therapeutics for a
Electra
A clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and
Expansion
A drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases.
Kate
A patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases.
Kyverna
A patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.
Latigo
A clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction.